Drug safety and reporting training

Drug Safety and Reporting Training.

Why do clinical trials need safety and reporting training?

Throughout the development phase of your medicinal product, it is critical that clinical trial sponsors and associated teams are able to create and follow a proactive managed approach to clinical safety and reporting. To ensure this, having the right training and training materials at study sites and beyond, is a necessary requirement for success.

Why choose Arriello for all your clinical drug safety and reporting training needs?

Our clinical safety consultants can prepare all your trial-specific Pharmacovigilance (PV) training materials and conduct all the applicable training for your personnel at study sites during Investigator Meetings, and also for Site Initiation Visits – especially important for Advanced Therapy Medicinal Products (ATMPs).

What our clients say about us.

Selected PV Case Studies.

Selected PV Case Studies.

Pharmacovigilance system, Europe, Local and global PV
EU expertise delivers results.
Local PV, regulatory strategy
23 Countries in two months.
Due Diligence, Regulatory, PV, Quality
Regulatory, PV and Quality Due Diligence.